COVID-19 caused by SARS-CoV-2 has posed a significant threat to global public health
since its outbreak in late 2019. Although there are a few drugs approved for clinical …

Objective The investigate the inhibitory effects of the traditional Chinese medicine (TCM)
monomer salvianolic acid B (Sal-B) and its magnesium salt Salvia Miltiorrhiza …

Middle East respiratory syndrome-related coronavirus (MERS-CoV) is the pathogen
responsible for the outbreak of MERS, and we are currently being affected by coronavirus …

Molecular docking studies were done to show the inhibitory effect of two naturally occurring
biflavone based anti-HIV agents, hinokiflavone and robustaflavone against the SARS-CoV-2 …

ABSTRACT The 2019 coronavirus disease (COVID-19), caused by the emerging severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed serious threats to …

SARS‐CoV‐2 caused the emerging epidemic of coronavirus disease in 2019 (COVID‐19).
To date, there are more than 82.9 million confirmed cases worldwide, there is no clinically …

There has been an immense effort by global pharmaceutical companies to develop anti-
COVID-19 drugs, including small molecule-based RNA replication inhibitors via drug …

Novel coronavirus disease 2019 (COVID-19), a respiratory disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought an unprecedented public …

Arbidol (ARB) is a broad-spectrum antiviral drug approved in Russia and China for the
treatment of influenza. ARB was tested in patients as a drug candidate for the treatment at …

The continuous emergence of SARS-CoV-2 variants prolongs COVID-19 pandemic.
Although SARS-CoV-2 vaccines and therapeutics are currently available, there is still a …